Cargando…
Prospects for the Use of Cannabinoids in Psychiatric Disorders
Increasing evidence suggests an essential role of the endocannabinoid system in modulating cognitive abilities, mood, stress, and sleep. The psychoactive effects of cannabis are described as euphoric, calming, anxiolytic, and sleep-inducing and positively affect the mood, but can also adversely affe...
Autores principales: | Graczyk, Michał, Łukowicz, Małgorzata, Dzierzanowski, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994770/ https://www.ncbi.nlm.nih.gov/pubmed/33776815 http://dx.doi.org/10.3389/fpsyt.2021.620073 |
Ejemplares similares
-
Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders
por: Blest-Hopley, Grace, et al.
Publicado: (2023) -
Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence
por: Dzierżanowski, Tomasz
Publicado: (2019) -
Cannabinoids—Perspectives for Individual Treatment in Selected Patients: Analysis of the Case Series
por: Graczyk, Michał, et al.
Publicado: (2022) -
Synthetic cannabinoids use in a sample of opioid-use disorder patients
por: Alías-Ferri, María, et al.
Publicado: (2022) -
Peripheral Endogenous Cannabinoid Levels Are Increased in Schizophrenia Patients Evaluated in a Psychiatric Emergency Setting
por: Potvin, Stéphane, et al.
Publicado: (2020)